These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21698503)

  • 1. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.
    Shen WF; Zhong W; Liu Q; Sui CJ; Huang YQ; Yang JM
    World J Surg; 2011 Sep; 35(9):2083-91. PubMed ID: 21698503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
    Liu G; Guo W; Wang H; Liu W; Lei L; Xie Q; Li X; Zou S; Wang P; Zhou H; Hu H
    Ann Palliat Med; 2021 Apr; 10(4):3673-3683. PubMed ID: 33691434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
    Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
    Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series.
    Wu ZF; Zhang HB; Yang N; Zhao WC; Fu Y; Yang GS
    Eur J Surg Oncol; 2012 Jul; 38(7):602-10. PubMed ID: 22417704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum gamma-glutamyl transferase levels affect the prognosis of patients with intrahepatic cholangiocarcinoma who receive postoperative adjuvant transcatheter arterial chemoembolization: A propensity score matching study.
    Lu Z; Liu S; Yi Y; Ni X; Wang J; Huang J; Fu Y; Cao Y; Zhou J; Fan J; Qiu S
    Int J Surg; 2017 Jan; 37():24-28. PubMed ID: 27756646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Transarterial Chemoembolization for Patients with Intrahepatic Cholangiocarcinoma after Surgical Resection: A Systematic Review and Meta-analysis.
    Wang L; Wen X; Zhuang L; Fang K; Shen J
    J Gastrointestin Liver Dis; 2022 Jun; 31(2):215-222. PubMed ID: 35574621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 13. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    Na SK; Choi GH; Lee HC; Shin YM; An J; Lee D; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
    PLoS One; 2018; 13(6):e0198138. PubMed ID: 29879137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study.
    Eltawil KM; Berry R; Abdolell M; Molinari M
    HPB (Oxford); 2012 May; 14(5):341-50. PubMed ID: 22487072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery.
    Park HM; Yun SP; Lee EC; Lee SD; Han SS; Kim SH; Park SJ
    Ann Surg Oncol; 2016 Dec; 23(13):4392-4400. PubMed ID: 27581609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
    Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.
    Burger I; Hong K; Schulick R; Georgiades C; Thuluvath P; Choti M; Kamel I; Geschwind JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):353-61. PubMed ID: 15758131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization.
    Liu JB; Chu KJ; Ling CC; Wu TM; Wang HM; Shi Y; Li ZZ; Wang JH; Wu ZJ; Jiang XQ; Wang GR; Ma YS; Fu D
    Curr Probl Cancer; 2020 Dec; 44(6):100612. PubMed ID: 32517878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.
    Saiura A; Yamamoto J; Kokudo N; Koga R; Seki M; Hiki N; Yamada K; Natori T; Yamaguchi T
    Am J Surg; 2011 Feb; 201(2):203-8. PubMed ID: 19427630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study.
    Goerg F; Zimmermann M; Bruners P; Neumann U; Luedde T; Kuhl C
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1709-1717. PubMed ID: 31578633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.